Clinical Trials Related to Small Cell Lung Cancer

Related studies linked through entity extraction aliases.

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Status: NOT_YET_RECRUITING
Phase: PHASE4

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE1

ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE1

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer

Status: RECRUITING
Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Status: RECRUITING
Phase: PHASE1/PHASE2

Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab

Status: RECRUITING
Phase: PHASE2

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

Status: RECRUITING
Phase: PHASE2

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

Status: ENROLLING_BY_INVITATION
Phase: EARLY_PHASE1

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Status: NOT_YET_RECRUITING
Phase: PHASE2

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Status: RECRUITING
Phase: N/A

Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE1

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE3

A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE1

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Status: RECRUITING
Phase: PHASE1

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE3

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

Status: RECRUITING
Phase: PHASE1

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE3